13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001696802
Total reported value
$92.0M
$92.0M
43 檔
72.8%
During the Q4 2025 filing period, Forefront Analytics, LLC (CIK: 0001696802) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $92.0M across 43 reported positions.
In Q4 2025, Forefront Analytics, LLC displayed an active expansion posture, initiating 4 new positions and adding to 28 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ESGD | Ishares Trust Ishares Esg Aw | ETF-Other | 17.73% | -10.48% | +14.02% | |
| 2 | ESGE | Ishares Inc Ishares Esg Awar | ETF-Other | 14.18% | -3.85% | +83.71% | |
| 3 | MTUM | Ishares Msci USA Momentum Fa | ETF-Other | 11.19% | +3.81% | +35.08% | |
| 4 | VWO | Vanguard Ftse Emerging Marke | ETF-Emerging Markets | 8.60% | +2.84% | +32.46% | |
| 5 | HDV | Ishares Core High Dividend E | ETF-Other | 7.44% | +1.81% | +73.75% | |
| 6 | VEA | Vanguard Ftse Developed ETF | ETF-Other | 6.80% | +0.92% | +11.53% | |
| 7 | NULV | Nuveen Esg Large-cap Val ETF | ETF-Other | 5.62% | -0.45% | -42.98% | |
| 8 | DBEF | Xtrackers Msci Eafe Hedged E | ETF-Other | 5.43% | +1.82% | +6.85% | |
| 9 | ESGG | Flexshares Stoxx Global Esg | ETF-Other | 4.17% | -2.55% | -5.63% | |
| 10 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 2.85% | +0.96% | +16.34% | |
| 11 | NVDA | Nvidia CORP | Stock-Tech | 2.30% | +1.99% | +0.01% | |
| 12 | AOK | Ishares Core 30/70 Conservat | ETF-Other | 2.08% | — | — | |
| 13 | HEEM | Ishares Crncy Hedgd Msci Em | ETF-Other | 1.85% | +0.86% | +24.18% | |
| 14 | JPM | Jpmorgan Chase & Co | Stock-Financials | 0.95% | +0.45% | +0.48% | |
| 15 | EES | Wisdomtree US Smallcap Fund | ETF-Other | 0.89% | +0.09% | -0.89% | |
| 16 | EMLP | First Trust North American E | ETF-Other | 0.62% | — | -2.74% | |
| 17 | VTV | Vanguard Value ETF | ETF-Other | 0.58% | +0.02% | -78.93% | |
| 18 | IEI | Ishares 3-7 Year Treasury Bo | ETF-Gov Bonds | 0.50% | — | -3.34% | |
| 19 | DE | Deere & Co | Stock-Industrials | 0.47% | +0.23% | +0.35% | |
| 20 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 0.46% | +0.13% | +36.09% | |
| 21 | INCY | Incyte CORP | Stock-Healthcare | 0.45% | +0.27% | +38.84% | |
| 22 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 0.42% | +0.15% | +28.50% | |
| 23 | PFE | Pfizer Inc | Stock-Healthcare | 0.42% | +0.15% | +51.88% | |
| 24 | SSO | Proshares Ultra S&p500 | ETF-Other | 0.42% | +0.21% | +100.34% | |
| 25 | ABT | Abbott Laboratories | Stock-Healthcare | 0.42% | +0.09% | +24.70% | |
| 26 | MDT | Medtronic plc | Stock-Healthcare | 0.36% | +0.03% | +3.26% | |
| 27 | UWM | Proshares Ultra Russell2000 | ETF-Other | 0.33% | +0.24% | +0.40% | |
| 28 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 0.30% | +0.10% | — | |
| 29 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 0.29% | -0.04% | +3.64% | |
| 30 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | ETF-High Yield | 0.23% | — | +1.89% | |
| 31 | TIP | Ishares Tips Bond ETF | ETF-Other | 0.22% | — | +0.77% | |
| 32 | IGF | Ishares Global Infrastructur | ETF-Other | 0.22% | — | +1.61% | |
| 33 | PM | Philip Morris International | Stock-Consumer Staples | 0.20% | +0.07% | +0.91% | |
| 34 | LQD | Ishr Ibx Usd Invgd Cb Etf-ui | ETF-Corp Bonds | 0.20% | — | +1.51% | |
| 35 | MIRM | Mirum Pharmaceuticals Inc | Stock-Other | 0.19% | — | — | |
| 36 | DHR | Danaher CORP | Stock-Healthcare | 0.18% | +0.20% | -30.31% | |
| 37 | ✓ | Zura Bio LTD | Stock-Other | 0.09% | +0.09% | -9.02% | |
| 38 | BCYC | Bicycle Therapeutics Plc-adr | Stock-Other | 0.08% | +0.04% | — | |
| 39 | CTMX | Cytomx Therapeutics Inc | Stock-Other | 0.07% | +0.05% | +3.26% | |
| 40 | NKTX | Nkarta Inc | Stock-Other | 0.07% | +0.01% | +3.17% | |
| 41 | GERN | Geron CORP | Stock-Other | 0.06% | +0.05% | -1.79% | |
| 42 | ANNX | Annexon Inc | Stock-Other | 0.06% | +0.02% | -51.06% | |
| 43 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.01% | -0.04% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ESGE | Ishares Inc Ishares Esg Awar | +5.9% | +83.71% | Add |
| 2 | HDV | Ishares Core High Dividend E | +2.7% | +73.75% | Add |
| 3 | MTUM | Ishares Msci USA Momentum Fa | +1.9% | +35.08% | Add |
| 4 | VWO | Vanguard Ftse Emerging Marke | +1.5% | +32.46% | Add |
| 5 | ESGD | Ishares Trust Ishares Esg Aw | +1.1% | +14.02% | Add |
| 6 | VEA | Vanguard Ftse Developed ETF | +0.4% | +11.53% | Add |
| 7 | HEEM | Ishares Crncy Hedgd Msci Em | +0.3% | +24.18% | Add |
| 8 | IVV | Ishares Core S&p 500 ETF | +0.2% | +16.34% | Add |
| 9 | INCY | Incyte CORP | +0.1% | +38.84% | Add |
| 10 | EW | Edwards Lifesciences CORP | +0.1% | +36.09% | Add |
| 11 | PFE | Pfizer Inc | +0.1% | +51.88% | Add |
| 12 | DBEF | Xtrackers Msci Eafe Hedged E | +0.1% | +6.85% | Add |
| 13 | REGN | Regeneron Pharmaceuticals | +0.1% | +3.64% | Add |
| 14 | UNH | Unitedhealth Group Inc | 0% | +28.50% | Add |
| 15 | ABT | Abbott Laboratories | 0% | +24.70% | Add |
| 16 | CTMX | Cytomx Therapeutics Inc | 0% | +3.26% | Add |
| 17 | ✓ | Zura Bio LTD | — | -9.02% | Trim |
| 18 | NKTX | Nkarta Inc | 0% | +3.17% | Add |
| 19 | IGF | Ishares Global Infrastructur | 0% | +1.61% | Add |
| 20 | GERN | Geron CORP | 0% | -1.79% | Trim |
| 21 | LQD | Ishr Ibx Usd Invgd Cb Etf-ui | 0% | +1.51% | Add |
| 22 | MDT | Medtronic plc | 0% | +3.26% | Add |
| 23 | ANNX | Annexon Inc | 0% | -51.06% | Trim |
| 24 | SSO | Proshares Ultra S&p500 | 0% | +100.34% | Add |
| 25 | UWM | Proshares Ultra Russell2000 | 0% | +0.40% | Add |
| 26 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | 0% | +1.89% | Add |
| 27 | TIP | Ishares Tips Bond ETF | 0% | +0.77% | Add |
| 28 | PM | Philip Morris International | 0% | +0.91% | Add |
| 29 | DE | Deere & Co | 0% | +0.35% | Add |
| 30 | MREO | Mereo Biopharma Group Pl-adr | -0.1% | -4.26% | Trim |
| 31 | JPM | Jpmorgan Chase & Co | -0.1% | +0.48% | Add |
| 32 | IEI | Ishares 3-7 Year Treasury Bo | -0.1% | -3.34% | Trim |
| 33 | DHR | Danaher CORP | -0.1% | -30.31% | Trim |
| 34 | EES | Wisdomtree US Smallcap Fund | -0.1% | -0.89% | Trim |
| 35 | EMLP | First Trust North American E | -0.1% | -2.74% | Trim |
| 36 | NVDA | Nvidia CORP | -0.2% | +0.01% | Add |
| 37 | ESGG | Flexshares Stoxx Global Esg | -0.5% | -5.63% | Trim |
| 38 | VTV | Vanguard Value ETF | -2.4% | -78.93% | Trim |
| 39 | NULV | Nuveen Esg Large-cap Val ETF | -4.9% | -42.98% | Trim |
| 40 | USMV | Ishares Msci USA Min Vol Fac | — | EXIT | Sold out |
| 41 | VB | Vanguard Small-cap ETF | — | EXIT | Sold out |
| 42 | AOK | Ishares Core 30/70 Conservat | — | NEW | New buy |
| 43 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | EXIT | Sold out |
| 44 | EDV | Vanguard Extended Dur Treas | — | EXIT | Sold out |
| 45 | TMO | Thermo Fisher Scientific Inc | — | NEW | New buy |
| 46 | MIRM | Mirum Pharmaceuticals Inc | — | NEW | New buy |
| 47 | BCYC | Bicycle Therapeutics Plc-adr | — | NEW | New buy |
According to official SEC Form 13F filings, Forefront Analytics, LLC reported a total U.S. public equity portfolio value of $92.0M across 43 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ESGD, ESGE, MTUM) accounted for 72.8% of total reported equity market value during Q4 2025.
Top New Position Initiated
AOK
市值: $2.4M
Top Position Liquidated / Trimmed
USMV
前期市值: $4.3M
During Q4 2025, Forefront Analytics, LLC's top holdings by market value included ESGD (17.7%)、ESGE (14.2%)、MTUM (11.2%). The largest single position, ESGD, represented 17.7% of total portfolio value.
In Q4 2025, Forefront Analytics, LLC made 47 total portfolio adjustments, initiating 4 new buys, adding to 28 positions, trimming 11 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.